Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Following SC orders,...

    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

    MD bureauWritten by MD bureau Published On 2020-02-23T11:45:49+05:30  |  Updated On 16 Aug 2021 11:18 AM IST
    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

    New Delhi: In continuation of the series of directives that the FDC Division, Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services,GoI, has issued yet another directive asking manufacturers/stakeholders to submit data on 66 fixed-dose combination drugs

    The CDSCO in its order has directed that manufacturers/stakeholders may submit the information/data w.r.t 49 FDCs as well as 17 FDCs. The last date of submitting the data is 30.05.2020. The move comes in Consideration of the directions of Hon'ble Supreme Court of India in the case of 294 FDCs.

    The notice issued by Dr VG Somani, Drug Controller General of India recently, stated

    In view of representations received in the matter for extension of time for submission, it has been considered the manufacturers/stakeholders may submit the information/data w.r.t 49 FDCs as well as 17 FDCs by 30.05.2020. Further, it may be informed that in case of failure to submit the data/information by 30.05.2020, the decision will be made on basis of information available before this office in light of the judgement of the Hon'ble Supreme Court.

    A copy of the DCGI letter has also been sent to all state drugs controllers, CDSCO Zonal and Sub-Zonal offices and Indian Drug or Pharmaceuticals Association Forum.

    Medical Dialogues team had earlier reported that the Central Drugs Standard Control Organization (CDSCO) has pulled up the Fixed-Dose Combination (FDCs) manufacturers and directed them to submit an application for category 'd' Fixed-Dose Combinations (FDCs) as per Kokate Committee Report by May 30, 2020.

    The Kokate Committee, headed by Prof. C. K. Kokate, Former Vice-Chancellor, KLE University, Karnataka, examined the Safety and Efficacy of unapproved FDCs which were licensed by State Licensing Authorities without due approval of DCGI.

    The Committee had examined 418 applications of FDCs and found 324 FDCs as irrational while only 28 FDCs as rational. The panel had further stated that they require more data for 2 FDCs and 4 FDCs require further deliberation. It was also observed that out of the remaining 60 FDCs, 48 FDCs have already been prohibited, 11 have been declared rational and one FDC is sub judice.

    The last date for filing such application was decided as November 22, 2019. However, with the expiry of the last date, CDSCO has provided another chance to the FDC manufacturers by giving them more time for submission of the application. In this regard, the apex drug regulator has extended the last date till May 30, 2020.

    Read Also: CDSCO pulls manufacturers for failing to submit application for category d FDCs; Details

    To check out the notice click on the following

    https://business.medicaldialogues.in/pdf_upload/pdf_upload-124643.pdf

    cdscodr-vg-somanisupreme-courtfda-bhawanFDC dugsfixed dose combination

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    MD bureau
    MD bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok